authors Lusk, Jay B O'Brien, Richard Aymes, Shannon Hammill, Bradley G Mac Grory, Brian Li, Fan O'Brien, Emily C Fitch, Kate Vinita Johnson, Kim G Liu, Andy Lund, Jennifer L Thomas, Laine E McDevitt, Ryan Zhao, Anqi Heather Whitson, MD
Keywords Alzheimer's disease amyloid targeting therapies donanemab lecanemab safety target trial emulation